Register for our free email digests:
EDAP TMS SA
Division of Edap TMS SA
Latest From China NT Pharma Group Co. Ltd.
China’s Ministry of Public Security has made formal bribery charges against UK-based drug maker GlaxoSmithKline and former general manager Mark Reilly and two Chinese executives for bribing non-government agencies and personnel.
With four new drug approvals notched under its belt in four months, GlaxoSmithKline had several potential growth drivers to highlight during its third quarter earnings call, helping to deflect attention away from the bribery scandal in China.
With its large population, one-child policy and increasing emphasis on preventative care, China is poised for a vaccine boom. The catalyst for growth may come from the expected modernization of the country’s massive national immunization program.
Merck has expanded its collaboration with Zhifei, its vaccine partner in China, by signing a three-year RMB 4.5 billion distribution deal for HPV vaccine Gardasil. But left unanswered is whether Merck will walk away from a partnership with Sinopharm it had previously emphasized.
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- MRI, NMR
Surgical Equipment & Devices
- Minimally or Less Invasive
- Diagnostic Imaging Equipment & Supplies
- Therapeutic Areas
- Gynecological, Urological
- Western Europe
- Parent & Subsidiaries
- Edap TMS SA
- EDAP TMS SA
- Senior Management
Marc Oczachowski, CEO
François Dietsch, CFO
- Contact Info
EDAP TMS SA
Phone: (33) 472 153 150
4 rue du Dauphine
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.